Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.09-1.8%$1.39$0.77▼$8.65$204.09M0.736.59 million shs4.60 million shsCRONCronos Group$2.01-2.0%$1.99$1.60▼$2.54$790.65M1.031.37 million shs1.78 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-1.80%-3.54%-15.50%-8.40%-85.37%CRONCronos Group-1.95%-3.83%+5.24%+13.56%-17.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCGCCanopy Growth0.4775 of 5 stars0.02.00.00.02.70.01.3CRONCronos Group2.0409 of 5 stars0.04.00.00.02.60.02.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 1.00SellN/AN/ACRONCronos Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CGC and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/30/2025CGCCanopy GrowthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderweight ➝ Underweight(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$225.65M0.89N/AN/A$1.90 per share0.57CRONCronos Group$117.61M6.59$0.00 per share4,405.57$2.90 per share0.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$4.04N/AN/AN/A-195.76%-88.54%-40.78%8/8/2025 (Estimated)CRONCronos Group$41.08M$0.1315.4667.00N/A39.69%-0.07%-0.07%8/6/2025 (Estimated)Latest CGC and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CRONCronos Group-$0.02N/AN/AN/AN/AN/A8/8/2025Q1 2026CGCCanopy Growth-$0.10N/AN/AN/A$64.98 millionN/A5/30/2025Q4 2025CGCCanopy Growth-$0.28-$0.94-$0.66-$1.00$71.84 million$45.30 million5/8/2025Q1 2025CRONCronos Group$0.01$0.02+$0.01$0.02$45.44 million$33.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.623.122.10CRONCronos GroupN/A27.8026.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth1.30%CRONCronos Group7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150183.87 million181.48 millionOptionableCRONCronos Group450385.68 million357.53 millionOptionableCGC and CRON HeadlinesRecent News About These CompaniesHigh Tide Closes on $30 Million Convertible Debt from Cronos Group Inc.July 16 at 4:01 PM | prnewswire.com3 Top Canadian Marijuana Stocks To Watch As The Sector Looks To BounceJuly 14, 2025 | marijuanastocks.comM3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry GrowthJuly 11, 2025 | marijuanastocks.comMCronos price extends gains as on-chain transactions spike 37%July 10, 2025 | invezz.comICryptocurrencies Price Prediction: Zcash, Bitcoin & Cronos — Asian Wrap 9 JulyJuly 9, 2025 | fxstreet.comNews Explorer — Cronos Price Jumps as Trump Media Plans ETF With Bitcoin, Ethereum, Solana and XRP AlongsideJuly 8, 2025 | decrypt.coDBig Tobacco Is Selling A Corporate Cannabis Blueprint As A Public Mandate, Former New York Regulator Says (Op-Ed)July 3, 2025 | marijuanamoment.netMNew Strong Buy Stocks for July 3rdJuly 3, 2025 | zacks.comCronos Grows its International Footprint in SwitzerlandJuly 2, 2025 | financialpost.comFCronos Grows its International Footprint in SwitzerlandJuly 2, 2025 | globenewswire.comCronos Group (NASDAQ:CRON) Trading Up 0.5% - Still a Buy?June 30, 2025 | marketbeat.comCronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders | CRON Stock NewsJune 23, 2025 | gurufocus.comCronos Group Inc. Announces Results of 2025 Annual Meeting of ShareholdersJune 23, 2025 | financialpost.comFCronos Group Inc. Announces Results of 2025 Annual Meeting of ShareholdersJune 23, 2025 | globenewswire.com3 Cannabis Stocks For Investors To Secure For Future GainsJune 20, 2025 | marijuanastocks.comM3 Marijuana Stocks For Longterm InvestorsJune 11, 2025 | marijuanastocks.comMCronos Group And 2 Other Noteworthy Penny Stocks On The TSXJune 9, 2025 | finance.yahoo.comMarijuana Stocks To Watch With Strong Market PotentialJune 6, 2025 | marijuanastocks.comMCronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer ConferenceJune 2, 2025 | financialpost.comFCronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer ConferenceJune 2, 2025 | investing.comCronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer ConferenceJune 2, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCGC and CRON Company DescriptionsCanopy Growth NASDAQ:CGC$1.09 -0.02 (-1.80%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.09 +0.00 (+0.09%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.01 -0.04 (-1.95%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.00 -0.01 (-0.75%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
